Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,647 public trials 305 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV

NCT00027365

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • San Francisco Vaccine and Prevention CRS San Francisco, California, United States
  • Johns Hopkins Bloomberg School of Public Health,Ctr for Immunization Research, Project SAVE-Baltimore Baltimore, Maryland, United States
  • Project Brave HIV Vaccine CRS Baltimore, Maryland, United States
View all 15 locations
View Trial Details
Completed

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

NCT00011037

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Projeto Praça Onze/Hesfa Crs Rio de Janeiro, Brazil
  • Les Centres GHESKIO CRS Port-au-Prince, Haiti
  • Barranco CRS Lima, Peru
  • CCPRI Med. Ctr. - Med. Research Foundation of Trinidad & Tobago Port of Spain, Trinidad and Tobago
View Trial Details
Completed

Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102)

NCT01423825

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • Fenway Health (FH) CRS Boston, Massachusetts, United States
  • Soweto HVTN CRS Johannesburg, Gauteng, South Africa
  • Emavundleni CRS Cape Town, Western Cape, South Africa
View Trial Details
Completed

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

NCT00574600

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
  • Fenway Health (FH) CRS Boston, Massachusetts, United States
  • Soweto HVTN CRS Johannesburg, Gauteng, South Africa
  • Emavundleni CRS Cape Town, Western Cape, South Africa
View Trial Details
Completed

Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults

NCT00472719

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • Columbia P&S CRS New York, United States
  • New York Blood Center CRS New York, United States
View Trial Details
Completed

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

NCT00801697

Conditions
Adenoviridae Infections, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • Alabama CRS Birmingham, Alabama, United States
  • Bridge HIV CRS San Francisco, California, United States
  • The Hope Clinic of the Emory Vaccine Center CRS Decatur, Georgia, United States
  • Brigham and Women's Hospital Vaccine CRS (BWH VCRS) Boston, Massachusetts, United States
View Trial Details
Completed

Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

NCT00043511

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Vaccine CRS Birmingham, Alabama, United States
  • UCSF, Gen. Clinical Research Ctr., Mt. Zion Hosp. San Francisco, California, United States
  • San Francisco Vaccine and Prevention CRS San Francisco, California, United States
  • FHCRC/UW Vaccine CRS Seattle, Washington, United States
View Trial Details

Related conditions